Evidence map›Paper›PMID 28620049›Full record

ArticleThe Journal of biological chemistry2017

The X-linked deubiquitinase USP9X is an integral component of centrosome.

Qian Wang, Yiman Tang, Yue Xu, Shilei Xu, Yong Jiang, Qiuping Dong, Yongsheng Zhou, Wenshu Ge

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Ubiquitin system mutations in neurological diseases.Trends in biochemical sciences · 2024
    Review
  7. Review
  8. ATXN3 deubiquitinates YAP1 to promote tumor growth.American journal of cancer research · 2023
    Article
  9. Article
  10. Ubiquitination and Deubiquitination in Oral Disease.International journal of molecular sciences · 2021
    Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Qian WangNational Clinical Research Center for Cancer, Tianjin Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China.
Yiman TangDepartment of Prosthodontics, Peking University School and Hospital of Stomatology, Beijing 100081, China.
Yue XuNational Clinical Research Center for Cancer, Tianjin Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China.
Shilei XuNational Clinical Research Center for Cancer, Tianjin Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China.
Yong JiangDepartment of General Dentistry II, Peking University School and Hospital of Stomatology, Beijing 100081, China.
Qiuping DongNational Clinical Research Center for Cancer, Tianjin Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China.
Yongsheng ZhouDepartment of Prosthodontics, Peking University School and Hospital of Stomatology, Beijing 100081, China; National Engineering Laboratory for Digital and Material Technology of Stomatology, Beijing Key Laboratory of Digital Stomatology, Beijing 100081, China. Electronic address: kqzhouysh@hsc.pku.edu.cn.
Wenshu GeDepartment of General Dentistry II, Peking University School and Hospital of Stomatology, Beijing 100081, China. Electronic address: esther1234@hsc.pku.edu.cn.
Peking University · CNTianjin Medical University Cancer Institute and Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The X-linked deubiquitinase USP9X has been implicated in multiple pathological disorders including malignancies and X-linked intellectual disability. However, its biological function and substrate repertoire remain to be investigated. In this study, we utilized the tandem mass tag labeling assay to identify USP9X-regulated proteins and revealed that the expression of multiple genes is altered in USP9X-deficient cells. Interestingly, we showed that USP9X promotes stabilization of centrosome proteins PCM1 and CEP55 through its catalytic activity. Remarkably, we demonstrated that USP9X is physically associated and spatially co-localized with PCM1 and CEP55 in the centrosome, and we revealed that either PCM1 or CEP55 loss resulted in impairment of USP9X centrosome localization. Moreover, we showed that USP9X is required for centrosome duplication, and this effect is dependent on its catalytic activity and its N-terminal module, which is responsible for physical association of USP9X with PCM1 and CEP55. Collectively, our experiments identified USP9X as an integral component of the centrosome where it functions to stabilize PCM1 and CEP55 and promote centrosome biogenesis.

Indexed as

Gene Expression RegulationAmino Acid SubstitutionAutoantigensCell Cycle ProteinsCell Line, TumorCentrosomeGene DeletionHumansImmunoprecipitationMutationNuclear ProteinsOligopeptidesOrganelle BiogenesisPeptide FragmentsProtein Interaction Domains and MotifsProtein StabilityAutoantigensCell Cycle ProteinsCep55 protein, humanFLAG peptideNuclear ProteinsOligopeptidesPCM1 protein, humanPeptide FragmentsRecombinant Fusion ProteinsUbiquitin ThiolesteraseUSP9X protein, humancentrosomedeubiquitylation (deubiquitination)protein-protein interactionprotein stabilityproteomics

Identifiers

PMID28620049
PMCPMC5546028
OpenAlexW2625082192

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.